Your Article Summary
See Latest ArticlesQuantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
Multiple Sclerosis, 06/30/09
Khalil M et al. – Quantitative assessment by R2* relaxometry suggests increased iron deposition in the basal ganglia of multiple sclerosis (MS) pts, associated with disease duration and brain atrophy. This technique, with long-term follow-up may clarify whether regional iron accumulation contributes to MS morbidity or merely reflects an epiphenomenon.
Methods- Study of regional brain iron deposition in pts with a clinically isolated syndrome (CIS) or relapsing–remitting MS (RRMS) and its associations with demographical, clinical, and conventional magnetic resonance imaging (MRI) parameters
- Assessment of 69 pts (32 CIS; 37 RRMS) with 3T MRI
- Analysis of regional R2* relaxation rates and correlations with age, disease duration, disability, T2 lesion load, and normalized brain volumes
- Basal ganglia R2* relaxation rates increased parallel with age; significantly higher in RRMS vs CIS
- On multivariate linear regression analysis, rate of putaminal iron deposition independently predicted by pt age, disease duration, and gray matter atrophy
Related Articles
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis
Multiple Sclerosis, 10/09/09
Relevance Score: 82%
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases
Journal of Neuroimmunology, 11/04/09
Relevance Score: 81%
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis
Multiple Sclerosis, 10/26/09
Relevance Score: 80%
Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient
Autoimmunity, 11/17/09
Relevance Score: 79%
Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09
Relevance Score: 69%
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis
Journal of Neurology, Neurosurgery, and Psychiatry , 12/17/09
HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia
Journal of Neuroimmunology, 12/16/09
The Prevalence of Multiple Sclerosis in 3 US Communities
Preventing Chronic Disease, 12/16/09